TELIX Pharmaceuticals Ltd Total Liabilities

Latest as of June 2025: AU$768.01 Million AUD ≈ $543.42 Million USD

TELIX Pharmaceuticals Ltd total liabilities. Based on the latest financial reports, TELIX Pharmaceuticals Ltd (TLX) has total liabilities worth AU$768.01 Million AUD (≈ $543.42 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check TLX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of TELIX Pharmaceuticals Ltd (2000–2024)

Total liabilities of TELIX Pharmaceuticals Ltd from 2000 to 2024. This chart illustrates how TELIX Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore TELIX Pharmaceuticals Ltd (TLX) investment intensity to see how much of total assets are deployed in long-term investments.

TELIX Pharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of TELIX Pharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
JA Solar Technology Co Ltd SHE:002459	China	CN¥80.82 Billion
SEB SA PA:SK	France	€6.13 Billion
Sinomach Heavy Equipment Group Co Ltd SHG:601399	China	CN¥18.98 Billion
Xinhu Zhongbao Co Ltd SHG:600208	China	CN¥51.51 Billion
Galaxy Digital Holdings Ltd NASDAQ:GLXY	USA	$8.12 Billion
ICU Medical Inc NASDAQ:ICUI	USA	$1.93 Billion
TISCO Financial Group Public Company Limited BK:TISCO	Thailand	฿240.46 Billion
Avista Corporation NYSE:AVA	USA	$5.63 Billion

Liability Composition Analysis (2000–2024)

This chart breaks down TELIX Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see TLX total asset value.

Liquidity & Leverage Metrics

TELIX Pharmaceuticals Ltd Total Liabilities Ratios Explained

TELIX Pharmaceuticals Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.82	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.65	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how TELIX Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for TELIX Pharmaceuticals Ltd (2000–2024)

The table below shows the annual total liabilities of TELIX Pharmaceuticals Ltd from 2000 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$948.22 Million ≈ $670.92 Million	+280.21%
2023-12-31	AU$249.39 Million ≈ $176.46 Million	+39.77%
2022-12-31	AU$178.44 Million ≈ $126.25 Million	+68.06%
2021-12-31	AU$106.17 Million ≈ $75.12 Million	+34.73%
2020-12-31	AU$78.81 Million ≈ $55.76 Million	+147.22%
2019-12-31	AU$31.88 Million ≈ $22.56 Million	+33.92%
2018-12-31	AU$23.80 Million ≈ $16.84 Million	+1221.74%
2017-12-31	AU$1.80 Million ≈ $1.27 Million	+411.63%
2000-12-31	AU$352.00K ≈ $249.06K	--

About TELIX Pharmaceuticals Ltd

AU:TLX Australia Biotechnology

Market Cap

$3.11 Billion

AU$4.39 Billion AUD

Market Cap Rank

#4633 Global

#118 in Australia

Share Price

AU$13.13

Change (1 day)

-2.60%

52-Week Range

AU$8.63 - AU$17.85

All Time High

AU$31.14